跳至主要内容
临床试验/NL-OMON22770
NL-OMON22770已完成不适用

ipid changes after induction therapy in patients with Inflammatory Bowel Disease: effect of different drug classes and inflammation

Erasmus Medical Center (investigator-initiated)0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • ii) IBD diagnosis, ii) age =>17 years, iii) starting systemic registered IBD drug therapy

排除标准

  • i) the use of lipid lowering drugs (with the exception of cholestyramine on stable dose throughout the study), ii) supplements containing plant sterols/stanols or cholestin, iii) pregnancy, iv) a history of liver transplantation

研究者

发起方
Erasmus Medical Center (investigator-initiated)

相似试验